Monday, December 18, 2017

Western Health Care System is the leading case of death and slowly it is eating its way to all other countries in the World

Hospital bills are mostly on the higher side today, and with the increasing number of private healthcare centres, the situation for the common man will only worsen, cautions well-known cardiologist and former Vice-Chancellor of Manipal University B. M. Hegde. The Hindu, 22 Sept 2014, Hyderabad edition.

You censured the western health care system during your talk. Why so?
Their health care is the leading cause of death. Take antibiotics for example. They are very dangerous, because when taken for treatment in excess, the body becomes resistant.

So what is the alternative? If I have fever, what do I take?
If you take a tablet to cure fever, it will bring down the temperature of your body, going against the natural course of cure. Most fevers – except malaria and a few others – are self-limiting, and after some time they recede. You should take rest and drink lot of fluids.

However, what happens today is the exact opposite. Why do you think doctors are not inclined towards helping people?
If hospitals and doctors become altruistic then their income will fall. The situation will improve if State-run hospitals are developed.

Can medical costs be low? Can you give an example?

Take the case of stents. They cost around $150 in the US, and if you cross waters from there and reach Cuba, it costs only five Pesos, equalling to few hundred rupees.

Anti-diabetes herbal drug - India

An anti-diabetes herbal drug, jointly developed by two Council of Scientific and Industrial Research (CSIR) laboratories has been launched in certain parts of North India. The drug, dubbed BGR-34, has been derived from the medicinal plant extracts as described in the ancient Ayurveda text.
BGR-34 been jointly developed by National Botanical Research Institute (NBRI) and Central Institute for Medicinal and Aromatic Plants (CIMAP). For the purpose of commercialisation, the drug licence has been awarded to Delhi-based Aimil Pharamaceuticals Pvt. Ltd. In return, Aimil will pay royalty based on drug sales to CSIR.
The drug is available in the form of a 500mg pill which needs to be consumed twice a day by a patient suffering from Type 2 diabetes. BGR-34 was recently approved by the Indian ministry that looks after traditional Indian medicines, AYUSH.
The Livemint reports that the drug was tested on a group of 1000 patients from the Indian states of Haryana, Delhi, Punjab, Karnataka and Himachal Pradesh. The study, which lasted for over a period of 18 months, found that the escalated blood glucose levels of 67 percent of the patients returned back to normal within three to four days of drug consumption.
“The modern diabetes drugs are known for side-effects and toxicity while BGR-34 works by controlling blood sugar and limiting the harmful effects of other drugs,” said NBRI scientist A.K.S. Rawat in a statement.
The Huffington Post reports that the drug has the capability to strengthen the immune system of the patient and also work as an antioxidant.

Contact the writer at feedback@ibtimes.com.au, or let us know what you think below.